Answers are grounded in this paper and cite their sources.
Background Surgical site infection (SSI) and wound disruption after laparoscopic cholecystectomy are uncommon but clinically important. We sought to identify patient and procedural factors associated with superficial incisional SSI, deep incisional SSI, organ/space SSI, and wound disruption within 30 days of surgery. Methods We performed a retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement Program Participant Use Files from 2018 through 2022. Adults undergoing laparoscopic cholecystectomy without intraoperative cholangiography (CPT 47562) were included. Four outcomes were modeled separately using multivariable logistic regression. Adjusted odds ratios (aORs), 95% confidence intervals (CIs), exact p-values, and areas under the receiver operating characteristic curve (AUCs) were reported. Results The cohort included 222,537 operations. Superficial incisional SSI occurred in 1,674 patients (0.75%), deep incisional SSI in 104 (0.05%), organ/space SSI in 2,119 (0.95%), and wound disruption in 142 (0.06%). Higher BMI and longer operative time were associated with superficial and deep SSI. Deep SSI was also associated with older age and diabetes. Organ/space SSI was associated with longer operative time, male sex, higher ASA class, diabetes, steroid use, disseminated cancer, dialysis, functional dependence, inpatient status, and preoperative SIRS or sepsis. Wound disruption was associated with higher BMI, male sex, longer operative time, and inpatient status. Discrimination was limited for superficial SSI and wound disruption and acceptable but not strong for deep and organ/space SSI. Conclusions Routinely available NSQIP variables identify groups with differing odds of postoperative infection and wound disruption, but the models have limited stand-alone clinical utility. The findings should inform counseling, optimization of modifiable risk factors, operative planning, and postoperative vigilance rather than delay an indicated cholecystectomy or justify nonoperative management or extended postoperative antibiotics.
No takes yet. Share an insight, caveat, or question.
Zapatier et al. (2026) studied this question.